2005•Inpharma WeeklyRequires access
Ribavirin plus didanosine-containing HAART regimens appear to be associated with an increased risk of mitochondrial toxicity,
&NA;
Open publisher page 0 citations
Abstract
This record does not include an abstract. Use the full-text link above if available.